The structure of natural subalpine spruce forest in the Zadna´Pol'ana massif of the Western Carpathians was analysed. We focused on the variability of different aspects of stand structure, tree decay and regeneration processes in altitudinal gradient. We used systematic sampling, covering an area of 2 km 2 , to detect even subtle changes in stand structure within one forest type over a range of less than 200 m in elevation. Mean stand density was 290 trees (>7 cm DBH) per hectare, average basal area was 41 m 2 ha À1 , and the volume accumulation in living trees amounted to 500 m 3 /ha À1 . Stand volume decreased by more than 50% between 1,260 and 1,434 m a.s.l. This means for an increase of altitude of 100 m that stand volume decreased by nearly 200 m 3 . Neither stand density nor basal area was related to elevation. Maximum tree height was strongly correlated to elevation, and it decreased on average by 6 m for each 100 m increment of altitude. No significant changes in the maximum spruce diameter were recorded in relation to the elevation gradient. Spatial distribution of trees was biased toward regularity at lower altitudes. Tree clustering increased with increasing altitude. The stock of coarse woody debris (CWD) decreased slightly along the altitudinal gradient, but changes were not significant. Density of spruce saplings and their number growing on CWD significantly increased across the elevation gradient. Despite the fact that the analysed forest tract was relatively large, highly variable in respect to environmental factors, and that stand volume, spatial structure, and tree height displayed strong variability along the elevation gradient, the diameter structure of stands and regeneration measures were uniform. Our results suggest that the recruitment of new trees in the Zadna´Pol'ana subalpine spruce forest is not temporally continuous even at a scale of several square kilometres.

Antibiotic resistance is notably high in Poland currently, but both tailored and empiric therapies can achieve acceptable cure rates equal to or higher than 90%.

Helicobacter pylori is one of the major stomach microbiome components, promoting development of inflammation and gastric cancer in humans. H. pylori has a unique ability to transform into a coccoidal form which is difficult to detect by many diagnostic methods, such as urease activity detection, and even histopathological examination. Here we present a comparison of three methods for H. pylori identification: histological assessment (with eosin, hematoxylin, and Giemsa staining), polymerase chain reaction (PCR) detection of urease (ureA specific primers), and detection by 16S rRNA gene sequencing. The study employed biopsies from the antral part of the stomach (N = 40). All samples were assessed histologically which revealed H. pylori in eight patients. Bacterial DNA isolated from the bioptates was used as a template for PCR reaction and 16S rRNA gene sequencing that revealed H. pylori in 13 and in 20 patients, respectively. Thus, 16S rRNA gene sequencing was the most sensitive method for detection of H. pylori in stomach biopsy samples.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally; recognition of immune responses to this virus will be crucial for coronavirus disease 2019 (COVID-19) control, prevention and treatment. We comprehensively analysed IgG and IgA antibody responses to the SARS-CoV-2 nucleocapsid protein (N), spike protein domain 1 (S1) and envelope protein (E) in: SARS-CoV-2-infected patient, healthy, historical and pre-epidemic samples, including patients’ medical, epidemiological and diagnostic data, virus-neutralizing capability and kinetics. N-specific IgG and IgA are the most reliable diagnostic targets for infection. Serum IgG levels correlate to IgA levels. Half a year after infection, anti-N and anti-S1 IgG decreased, but sera preserved virus-inhibitory potency; thus, testing for IgG may underestimate the protective potential of antibodies. Historical and pre-epidemic sera did not inhibit SARS-CoV-2, thus its circulation before the pandemic and a protective role from antibodies pre-induced by other coronaviruses cannot be confirmed by this study

Background. Endovascular abdominal aortic aneurysm repair has become an alternative to open surgical repair of abdominal aortic aneurysm since the early 1990s. The conventional method remains the gold standard in the treatment of Abdominal Aortic Aneurysm (AAA); however, a large percentage of patients do not qualify for this treatment due to the high risk of perioperational death and complications. Objectives. The objective of this work was to compare AAA surgeries performed by both classical and endovascular methods in years 2002-2011. Material and Methods. Medical documentation of elective AAA patients undergoing surgical treatment was retrospectively analyzed on the basis of archive-and computer database data. The analysis included the patients' demographics, internal disease burden, as well as causes of deaths and complications within 30 days after the procedure and 1 year follow-up. Results. Thirty-day and 1-year mortality rates in patients treated in the elective setting were 1.5% and 8.7% for endovascular method and 4.0% and 15.7% for the open method. The comparison of mortality rates in 115 high-risk patients undergoing elective OR treatment with 275 high-risk treatment patients undergoing EVAR surgery (7.8% vs. 1.5%, 8.7% vs. 15.7%, p < .01) showed that the endovascular method significantly reduced the mortality in the latter group. Conclusions. Endovascular treatment is an attractive option in AAA; especially in heavily burdened patients, because it definitely reduces mortality. EVAR was found to be advantageous over OR in case of high-risk patients (Adv Clin Exp Med 2015, 24, 3, 475-479).

No abstract

No abstract

Background: Abdominal aortic aneurysm (AAA) remains a surgical challenge. There are many recognizable markers associated with the formation of AAA. Previous experiments carried out on animal models have shown a correlation between serum calprotectin and the occurrence of AAA. Objective: This study aimed to evaluate the level of calprotectin as a potential diagnostic biomarker in patients with diagnosed AAA. Method: The study group consisted of 75 patients aged 35–75 years who were assigned to two groups: a control group (n=43) of healthy subjects without AAA and a study group (n=32) of patients with a diagnosed AAA. The first calprotectin test was performed upon patient admission to the hospital, and the second control test was performed after three months. The concentration of calprotectin in plasma was determined using the immunoenzymatic method (ELISA) with the commercially available Assaypro Kit (AssayMax™ Human Calprotectin ELISA Kit), as well as the sandwich method with polyclonal antibodies to human calprotectin and peroxidase enzyme. Results & Discussion: Serum calprotectin levels in AAA patients were three times higher than in healthy subjects (p<0.05). A statistically significant a twofold decrease in calprotectin concentration was observed after AAA surgery in comparison with the control group (p<0.05). Conclusion: Calprotectin levels can be an important marker in the detection of AAA. In conclusion, AAA patients showed a threefold increase in serum calprotectin level and a twofold decrease in this marker after AAA surgery.